HPV education for women: effects on knowledge, screening, and vaccination
"Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study"
This project will try online HPV education for women aged 18–35 to see if it improves their HPV knowledge, increases screening, and raises vaccination uptake.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | Female |
| Sponsor | Ufuk University Academic / other |
| Locations | 1 site (Ankara, Ankara) |
| Trial ID | NCT07320157 on ClinicalTrials.gov |
What this trial studies
This observational project will compare a group of women who receive online HPV education with a control group who do not receive the training. Participants will be assigned to intervention or control arms and the intervention group will complete an online training session delivered by the research team. Outcomes include change in HPV Knowledge Scale scores, participation in HPV screening tests, and HPV vaccination status over the study period. The study is conducted in Ankara, Turkey, and uses video interviews and questionnaires to collect data from eligible participants.
Who should consider this trial
Good fit: Women aged 18–35 who speak Turkish, have not had the HPV vaccine or HPV DNA/Pap testing in the past five years, have no HPV or cervical cancer diagnosis, and can participate in video interviews are ideal candidates.
Not a fit: Women who are already vaccinated, have recent HPV/Pap testing, have an HPV-positive or cervical cancer diagnosis, are outside the 18–35 age range, or cannot use the required video technology are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the education could increase HPV awareness and lead to higher screening and vaccination rates among young women.
How similar studies have performed: Prior education programs have generally improved HPV knowledge and in some cases have increased screening and vaccination uptake, so similar approaches have shown promise.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being female * Women aged 18-35 years * Ability to speak and understand Turkish at a level sufficient to communicate with the researcher * Having the technical equipment necessary to participate in a video interview * No diagnosis of HPV positivity * Not having received the HPV vaccine * Not having undergone HPV DNA/Pap smear testing in the past 5 years * No diagnosis of cervical cancer * Voluntary willingness to participate in the study * No diagnosis of a psychiatric disorder Exclusion Criteria: * Being male * Having severe physical or cognitive impairments that prevent completing the questionnaire * Being under 18 years of age or over 35 years of age * Inability to speak or understand Turkish * Lack of technical equipment to participate in a video interview * Having a diagnosis of HPV positivity * Having received the HPV vaccine * Having undergone HPV DNA/Pap smear testing in the past 5 years * Having a diagnosis of cervical cancer * Having a diagnosed psychiatric disorder Not agreeing to participate in the study
Where this trial is running
Ankara, Ankara
- UfUk UNİVERSİTY — Ankara, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Gi̇zem B Bi̇lmez Gi̇zem, Phd Student
- Email: gzm_erdogan@hotmail.com
- Phone: 905532657387
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.